Concord Biotech
Company Overview - January 14, 2025
Concord Biotech is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on both the BSE (Code: 543960) and NSE (Code: CONCORDBIO). As of the January 14, 2025, the company holds a market capitalization of INR 21802.52 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 2084.05, Concord Biotech has demonstrated a 52.13% return over the last year. Recent performance indicates fluctuations, with a 0.71% change in the past week and a 12.61% change over the last month. The company's all-time high stands at INR 2664.00, while its lowest-ever price was INR 900.00.
In terms of sales, Concord Biotech reported a revenue of INR 1085.75 crores, solidifying its position in the market. The average trading volume over the past month has been 98579 shares, with a more recent weekly average of 93830.
With the stock trading above its 50-day moving average of INR 1910.91, the company's technical indicators like MACD (41.33) signal positive trends.
Company Data
| Name | Concord Biotech |
|---|---|
| BSE Code | 543960 |
| NSE Code | CONCORDBIO |
| Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Current Price | 2084.05 |
| Market Capitalization | 21802.52 |
| Sales | 1085.75 |
| Return over 3months | 22.08 |
| Return over 6months | 38.96 |
| Volume 1month average | 98579 |
| Volume 1week average | 93830 |
| Volume | 37556 |
| High price | 2664.00 |
| Low price | 1277.75 |
| High price all time | 2664.00 |
| Low price all time | 900.00 |
| Return over 1day | 2.33 |
| Return over 1week | 0.71 |
| Return over 1month | 12.61 |
| Return over 1year | 52.13 |
| Return over 3years | |
| Return over 5years | |
| Volume 1year average | 179192 |
| DMA 50 | 1910.91 |
| DMA 200 | 1688.70 |
| DMA 50 previous day | 1905.90 |
| DMA 200 previous day | 1685.24 |
| MACD | 41.33 |
| MACD Signal | 17.13 |